Feto-Maternal Outcome in Pregnant Women with Morbidly Adherent Placenta

Authors

  • Zeenat Lady Reading Hospital MTI Peshawar, Pakistan
  • Sumaira Yasmin Lady Reading Hospital MTI Peshawar, Pakistan
  • Sana Ali Afridi Lady Reading Hospital MTI Peshawar, Pakistan
  • Zia Ur Rehman Lady Reading Hospital MTI Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i4.3019

Keywords:

Fetal growth retardation, Placenta accreta, Hysterectomy, Postpartum haemorrhage, Pregnancy complications

Abstract

Background: Morbidly adherent placenta is a serious obstetric conditions in which placenta abnormally attached to uterus and cannot be separated easily. It is associated with high maternal and fetal complication especially in settings with increasing caesarean section rate and poor antenatal care. Objective: To determine the frequency of feto-maternal outcomes in pregnant women with morbidly adherent placenta. Study Design: Cross sectional study. Duration and Place of Study: This study was carried out from April 2024 to October 2024 in Department of Obstetrics and Gynaecology, Lady Reading Hospital, Peshawar. Methodology: A total of 87 pregnant women aged 18–40 years with diagnosis of morbidly adherent placenta on ultrasonography were included. Patients were followed till delivery and immediate postpartum period. Mean and standard deviation were calculated for numerical variables, while frequencies and percentages were calculated for categorical variables using Statistical Package for Social Sciences version 23. Results: Mean age was 31.62 ± 4.96 years and mean gestational age was 34.74 ± 2.39 weeks. Neonatal intensive care unit admission was seen in 34(39.1%) cases. Fetal growth restriction was observed in 20(23.0%) cases, while intrauterine fetal demise was noted in 3(3.4%) cases. Postpartum haemorrhage occurred in 40(46.0%) women. Hysterectomy was performed in 62(71.3%) patients. Conclusion: Morbidly adherent placenta is associated with high maternal and fetal morbidity. Postpartum haemorrhage and hysterectomy were most common maternal complications.

Downloads

Download data is not yet available.

References

1. Einerson BD, Gilner JB, Zuckerwise LC. Placenta accreta spectrum. Obstet Gynecol. 2023; 142(1):31-50.

https://doi.org/10.1097/AOG.0000000000005229

2. Dutta S, Dey B, Chanu S, Marbaniang E, Sharma N, Khonglah Y, et al. A retrospective study of placenta accreta, percreta, and increta in peripartum hysterectomies in a tertiary care institute in northeast India. Cureus. 2020; 12(11):e11399.

https://doi.org/10.7759/cureus.11399

3. Wenqiang D, Novin A, Liu Y, Afzal J, Suhail Y, Liu S, et al. Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum. Nat Commun. 2024; 15(1):8379.

https://doi.org/10.1038/s41467-024-52351-0

4. Afshar Y, Kashani Ligumsky L, Bartels HC, Krakow D. Biology and pathophysiology of placenta accreta spectrum disorder. Obstet Gynecol. 2025; 145(6):611-620.

https://doi.org/10.1097/AOG.0000000000005903

5. Birendra R, Jigyasa S. A retrospective study of maternal and neonatal outcome in placenta accreta spectrum after planned or emergency delivery from a tertiary care centre in North India. Cureus. 2023; 15(9):e44725.

https://doi.org/10.7759/cureus.44725

6. Nguyen PN, Vuong ADB, Pham XTT. Neonatal outcomes in the surgical management of placenta accreta spectrum disorders: a retrospective single-center observational study from 468 Vietnamese pregnancies beyond 28 weeks of gestation. BMC Pregnancy Childbirth. 2024; 24(1):228.

https://doi.org/10.1186/s12884-024-06349-7

7. Bartels HC, Walsh JM, O'Connor C, McParland P, Carroll S, Higgins S, et al. Placenta accreta spectrum ultrasound stage and fetal growth. Int J Gynaecol Obstet. 2023; 160(3):955-961.

https://doi.org/10.1002/ijgo.14399

8. Zou J, Wei W, Xiao Y, Wang X, Wang K, Xie L, et al. Predicting placenta accreta spectrum and high postpartum hemorrhage risk using radiomics from T2-weighted MRI. BMC Pregnancy Childbirth. 2025; 25(1):398.

https://doi.org/10.1186/s12884-025-07516-0

9. Gatta LA, Weber JM, Gilner JB, Lee PS, Grotegut CA, Herbert KA, et al. Transfusion requirements with hybrid management of placenta accreta spectrum incorporating targeted embolization and a selective use of delayed hysterectomy. Am J Perinatol. 2022; 29(14):1503-1513.

https://doi.org/10.1055/s-0042-1754321

10. Tsolakidis D, Zouzoulas D, Pados G. Pregnancy-related hysterectomy for peripartum hemorrhage: a literature narrative review of the diagnosis, management, and techniques. Biomed Res Int. 2021; 2021:9958073.

https://doi.org/10.1155/2021/9958073

11. Abbas S, Shaikh F, Nabila Hasan S. Fetomaternal outcome in morbidly adherent placenta. Pak J Med Health Sci. 2023; 17(1):139-141.

https://doi.org/10.53350/pjmhs2023171139

12. Krupa BM, Swarup A, Padma, Geetha, Anand V, Shruthi S. Pregnancy outcomes in various types of placenta previa: a clinical study. J Gynecol Womens Health. 2021; 21(5):556073. https://doi.org/10.19080/JGWH.2021.21.556073

13. Khan S, Rawat RP, Meena S. Feto maternal outcome in placenta previa and morbidly adherent placenta. Int J Reprod Contracept Obstet Gynecol. 2023; 12(6):1655-1659.

https://doi.org/10.18203/2320-1770.ijrcog20231531

14. Tahir H, Iqbal S, Parveen K, Bibi S, Shaikh AG, Ali S. Morbidly adherent placenta in patients with placenta previa and feto-maternal outcomes. J Popul Ther Clin Pharmacol. 2024; 31(3):1037-1042. https://doi.org/10.53555/jptcp.v31i3.5075

15. Tahseen H, Khokhar S, Qurban S, Khurshid N, Tayyab M, Muneer N. Morbidly adherent placenta in patients with placenta previa and feto-maternal outcomes. J Soc Obstet Gynaecol Pak. 2023; 13(2):69-72.

16. Sultana N, Mohyuddin S, Jabbar T. Management and maternal outcome in morbidly adherent placenta. J Ayub Med Coll Abbottabad. 2011; 23(2):93-96.

17. Sharma P, Raina P, Sharma S. Feto-maternal outcome with placenta accreta spectrum: a cross-sectional study. Timisoara Med. 2021; 2021(2):3.

https://doi.org/10.35995/tmj20210203

18. Sultana R. Foeto-maternal outcome in women with placenta praevia and morbidly adherent placenta praevia. Ann Pak Inst Med Sci. 2022; 18(3):212-217.

https://doi.org/10.48036/apims.v18i3.635

19. Huma ZE, Zia U, Sadiq A, Saleem A, Noreen S, Aslam A. Maternal and neonatal health outcomes in placenta accreta: short-term morbidity and long-term neurodevelopmental impacts. Pak J Health Sci. 2025; 6(2):224-229.

https://doi.org/10.54393/pjhs.v6i2.2223

Downloads

Published

2025-04-30

How to Cite

Zeenat, Yasmin, S., Afridi, S. A., & Zia Ur Rehman. (2025). Feto-Maternal Outcome in Pregnant Women with Morbidly Adherent Placenta. Indus Journal of Bioscience Research, 3(4), 1345-1348. https://doi.org/10.70749/ijbr.v3i4.3019